Halberd Corp HALB

Halberd Corporation is a holding company. The Company is engaged in the acquisition vehicle for established businesses. It is also developing treatments for neurodegenerative diseases, such as post-traumatic stress disorder/chronic traumatic encephalopathy (PTSD/ CTE), Alzheimer’s disease and Parkinson’s disease. It has two issued patents and four provisional patent applications related to the extracorporeal treatment of blood-borne diseases and cerebrospinal fluid related diseases, with particular focus on the treatment and rapid detection of Covid-19 and other viruses. Its Sequential Dialysis Technique is a methodology that physically removes the pathophysiologic basis of the disease, eliminating it without side effects. The Company’s wholly owned subsidiary is Alaric Corporation.

OTCPK:HALB - Post by User

Halberd Corp > Extremely hot: HALB marches on successfully

<< Previous

Bullboard Posts

Next >>

Post by badgirl007on Apr 08, 2021 9:41am

78 Views

Post# 32955858

Extremely hot: HALB marches on successfully

Halberd is on the right track:

The meeting with William Hartman, Dr. Mitchell Felder and Dr. W. G. Sturrus, Chair of the Physics and Science Dept. of Youngstown State U. was great! Dr. Sturrus agreed to participate in the endeavor and concurred that Halberd is on the right track. Terms to be determined.
10:09 nachm. · 7. Apr. 2021

Dr. Sturrus is from Youngstown State University, their third research partner (ASU and GreenbioAZ Inc. the other two)

https://twitter.com/halberdc

<< Previous

Bullboard Posts

Next >>

One of the strongest contenders to lead Canada’s cannabis market